Chemistry & biodiversityAnimalsAntitubercular AgentsChemical and Drug Induced Liver InjuryMiceMetabolomics
Elucidating the Mechanism of Modified Yiguanjian against Anti-Tuberculosis Drug-Induced Liver Injury via Integrated Pharmacology and Metabolomics.
Yu Tu, Mingna Wei, Xuting Wu, Shunxia Du, Jian Ou, Jiangping Yang, Xuenian Liu, Jinglun Huang, Aijun Jiao, Changyuan Wu
Published: 202610.1002/cbdv.202501824
Abstract
This study aimed to investigate the therapeutic effects and molecular mechanisms of Modified Yiguanjian (MYGJ) in treating anti-tuberculosis drug-induced liver injury (ATB-DILI). ATB-DILI is a serious side effect of TB treatment, often leading to liv…
Preview only. Read the full abstract at the source